Evidence map›Paper›PMID 34023209›Full record

ArticleClinical lymphoma, myeloma & leukemia2021

Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.

Alexander Coltoff, Andrew Bomback, Shayan Shirazian, Suzanne Lentzsch, Divaya Bhutani

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical lymphoma, myeloma & leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander ColtoffDepartment of Medicine, Division of Hematology and Oncology, Columbia University.
Andrew BombackDepartment of Medicine, Division of Nephrology, Columbia University, New York, NY.
Shayan ShirazianDepartment of Medicine, Division of Nephrology, Columbia University, New York, NY.
Suzanne LentzschDepartment of Medicine, Division of Hematology and Oncology, Columbia University.
Divaya BhutaniDepartment of Medicine, Division of Hematology and Oncology, Columbia University. Electronic address: db3203@cumc.columbia.edu.

Funding

Molecular Oncology Training ProgramT32CA203703 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Katherine D Crew, DAWN HERSHMAN · 2016 to 2026
$4.1M
NCI NIH HHS T32 CA203703
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADP-ribosyl Cyclase 1AgedAntibodies, MonoclonalComplement C3FemaleGlomerulonephritis, MembranoproliferativeHumansKidney GlomerulusMaleParaproteinemiasTreatment OutcomeADP-ribosyl Cyclase 1Antibodies, MonoclonalComplement C3daratumumabC3 glomerulopathyMonoclonal gammopathy of renal significanceCd38MyelomaPlasma cellsTargeted therapy

Identifiers

PMID34023209
PMCPMC9245370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.